Evidence map›Paper›PMID 17625148›Full record

ReviewGut2007

Biology and management of pancreatic cancer.

Paula Ghaneh, Eithne Costello, John P Neoptolemos

Abstract readReview
In one paragraph

Review in Gut, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Laparoscopic versus open distal pancreatectomy for pancreatic cancer.The Cochrane database of systematic reviews · 2016
    Pooled it
  3. Pooled it
  4. Association of OGG1 Ser326Cys polymorphism and pancreatic cancer susceptibility: evidence from a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  5. Resection versus other treatments for locally advanced pancreatic cancer.The Cochrane database of systematic reviews · 2014
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. A Review of Emerging Biomarkers for Immune Checkpoint Inhibitors in Tumors of the Gastrointestinal Tract.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Review
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Paula GhanehDivision of Surgery and Oncology, University of Liverpool, Liverpool L69 3GA, UK.
Eithne Costello
John P Neoptolemos

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pancreatic NeoplasmsAdjuvants, PharmaceuticBiomarkers, TumorGenes, rasGenes, Tumor SuppressorHumansIntercellular Signaling Peptides and ProteinsModels, BiologicalNeoplasm StagingPancreasReceptors, Growth FactorSignal TransductionAdjuvants, PharmaceuticBiomarkers, TumorIntercellular Signaling Peptides and ProteinsReceptors, Growth Factor

Identifiers

PMID17625148
PMCPMC1955499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.